Myriad Genetics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 20, 2026, 8:36 a.m. ETView on SEC.gov
Entry into a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedMyriad Genetics to sell prenatal health testing business to Labcorp for $210 million cash plus inventory
8-KOct. 9, 2026, 4:16 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Financial statements and exhibits
8-KSept. 16, 2026, 8 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
8-KJuly 30, 2026, 4:07 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits